EMD Millipore Introduces DRYPOUR™ Packaging System To Minimize Caking Of Pharmaceutical Raw Materials
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, has introduced the DRYPOUR™ packaging system, which minimizes caking of hygroscopic salts used in pharmaceutical manufacturing during transport and storage. The system, which consists of a polyethylene drum with a tamper-evident seal, a polyethylene liner with integrated desiccant bags and a breathable interior Tyvek® liner, helps improve operational efficiency by reducing the time and effort needed to break up heavily caked raw materials.
The drum and polyethylene liner prevent outside moisture from entering the product. Any water vapor in the product itself can permeate the interior, tear-resistant Tyvek® liner, migrate into the outer polyethylene liner and be absorbed by the integrated desiccant. Unlike other packaging systems, the desiccant bags in the DRYPOUR™ system are fixed to the perforated polyethylene liner, thus preventing contact with the product, so product quality is not compromised. For maximum effect, the desiccant bags are mounted in varying places on the liner.
"The DRYPOUR™ packaging system addresses the shortcomings associated with existing packaging options, increasing operational efficiency and reducing the risk of contamination," noted Philip Schaefer, Head of Pharm Chemicals Solutions. "By integrating the desiccant directly into the liner system, hygroscopic salts are better protected from moisture with no exposure to the desiccant itself. Because caking is minimized with the DRYPOUR™ system, users no longer have to invest significant time and resources to break apart hardened chemicals, a manual process that also carries the risk of introducing contaminants."
A range of the company's line of EMPROVE® pharmaceutical raw materials is available in the DRYPOUR™ packaging system. The DRYPOUR™ system is available in 100 kilogram package sizes and can be moved with common handling devices. The system meets both European Pharmacopoeia and USP requirements.
For more information, please visit www.emdmillipore.com/drypour.
About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2012 revenues of €2.6 billion. EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany
Source: EMD Millipore